Matches in Nanopublications for { ?s ?p "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1016035.RAaTM155JyUyfZ9E5uqUuiR4f9PnY2J5VzRYHO2EZ6ak8130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016035.RAaTM155JyUyfZ9E5uqUuiR4f9PnY2J5VzRYHO2EZ6ak8130_provenance.
- NP581701.RAd66PGRvFkjN-4PN0NwyllvBGYHNWe7uovbk-DhwBhPM130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581701.RAd66PGRvFkjN-4PN0NwyllvBGYHNWe7uovbk-DhwBhPM130_provenance.
- NP581698.RAgwy9OwuInDauRa_6EntgSZ3gFjkPjN49iKUQaNyijYY130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581698.RAgwy9OwuInDauRa_6EntgSZ3gFjkPjN49iKUQaNyijYY130_provenance.
- NP268640.RA-AmO_Zt35-swRhOG68XUXIQln-IQiB1gYbjG2YsajG8130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268640.RA-AmO_Zt35-swRhOG68XUXIQln-IQiB1gYbjG2YsajG8130_provenance.
- NP1015994.RAHuvTLVJ0MJanuKOXJ6CRbi5v0o9yOURnNh_Qacwjihw130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015994.RAHuvTLVJ0MJanuKOXJ6CRbi5v0o9yOURnNh_Qacwjihw130_provenance.
- NP268681.RAL_FuQtSt0WaIq6AY8CEoxXy-P987k1PY0P3O95K841Q130_assertion description "[Whereas BMI1 and RING1 are abundantly present in prostate cancer, EZH2 is expressed at relatively low levels, making it a less obvious target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268681.RAL_FuQtSt0WaIq6AY8CEoxXy-P987k1PY0P3O95K841Q130_provenance.